What phase I trials has suzetrigine (suzetrigine) been in?
Suzetrigine is an investigational compound, but the provided information here does not include any specific details about its phase I clinical trials (for example, trial identifiers like NCT numbers, study locations, dosing plans, or the status/results).
How can I find the exact phase I suzetrigine trial(s) (NCT numbers, sites, and dosing)?
To look up the exact phase I studies for suzetrigine, the most reliable approach is to search by the compound name and filter for “Phase 1” on clinical trial registries (typically ClinicalTrials.gov and similar databases used by regulators). These listings usually show:
- Trial registry ID (e.g., NCT number)
- Sponsor/company
- Study design (single ascending dose vs. multiple ascending dose)
- Inclusion criteria and target population
- Dosing schedule and safety endpoints
Are there any results published from suzetrigine phase I?
The information you provided doesn’t include any phase I outcomes (such as safety/tolerability data, dose-limiting toxicities, pharmacokinetics, or reported efficacy signals). If you share the trial ID(s) or a link to a specific registry entry, I can help interpret what those phase I results mean.
What safety outcomes are phase I trials of suzetrigine designed to capture?
Phase I studies of investigational drugs typically focus on:
- Safety and tolerability (adverse events, lab abnormalities)
- Dose escalation/range finding (whether doses stop due to toxicity)
- Pharmacokinetics (how the body absorbs/metabolizes/excretes the drug)
- Pharmacodynamics (biomarker changes), if applicable to the program
But the exact endpoints used in suzetrigine phase I trials aren’t included in the information available here.
Can you share what you already have (so I can pinpoint the right trials)?
If you paste any of the following, I can identify the precise phase I trial(s) and summarize them:
- An NCT number
- A ClinicalTrials.gov link
- The sponsor name (company running the trial)
- The condition being studied (e.g., epilepsy, pain, etc.—if you know it)
Sources
No sources were provided in your prompt, and no trial-specific details about suzetrigine phase I were included.